Skip to Content

Top Stories

Experimental mRNA cancer vaccine with immunotherapy reduces risk of melanoma returning, preliminary study finds

By Jamie Gumbrecht, CNN An experimental personalized mRNA vaccine in combination with the immunotherapy Keytruda reduced the risk of recurrence or death from melanoma in patients who had already had surgery, Moderna and Merck said Tuesday. The randomized trial included 157 patients with stage 3 or stage 4 melanoma who had already had surgery. Some

Continue Reading